alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**Exhibit 31.1********CERTIFICATION**I, Sean A. Dobson, certify that: 1. I have reviewed this annual report on Form 10-K, and all reports on Form 8-K containing distribution or servicing reports filed in respect of periods included in the year covered by this annual report, of the USAutos Series 2004-1 Trust (the "Trust"); 2. Based on my knowledge, the information in these reports, taken as a whole, does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading as of the last day of the period covered by this annual report; 3. Based on my knowledge, the distribution or servicing information required to be provided to the Depositor by the Trustee under the pooling and servicing, or similar, agreement, for inclusion in these reports is included in these reports; 4. Based on my knowledge and upon the annual compliance statement included in the report and required to be delivered to the trustee in accordance with the terms of the pooling and servicing, or similar, agreement, and except as disclosed in the reports, the Depositor and the Trustee has each fulfilled its obligations under the servicing agreement; and 5. The reports disclose all significant deficiencies relating to the Depositor's and Trustee's compliance with the minimum servicing standards based upon the report provided by an independent public accountant, after conducting a review in compliance with the Uniform Single Attestation Program for Mortgage Bankers or similar procedure, as set forth in the pooling and servicing, or similar, agreement, that is included in these reports. In giving the certifications above, I have reasonably relied on information provided to me by the following unaffiliated party: U.S. Bank Trust National Association, as Trustee. Date:  March 19, 2009  /s/ Sean A. Dobson Sean A. Dobson, President
Exhibit 4.14



 Exhibit 4.14 
 AMENDMENT TO 
 WARRANT TO PURCHASE SHARES OF 

COMMON STOCK, NO PAR VALUE, OF 
 ROCKWELL MEDICAL TECHNOLOGIES, INC. 
 This Amendment
(“Amendment”), dated November 1, 2011, amends the Warrant dated June 19, 2009 and issued by Rockwell Medical Technologies, Inc. (“Company”) to Emerald Asset Advisors, LLC (“Holder”) as of November 5, 2008
(the “Warrant”). 
 WHEREAS, the Company and Holder have determined that the terms of this Amendment are in the
Company’s best interests and have provided written consent to this Amendment as required by Section 8(c) of the Warrant; 
 NOW THEREFORE, the Warrant is amended as set forth below. 
  

	 	1.	The second sentence of Section 1(b) of the Warrant is amended and restated in its entirety to read as follows: 


The Tranche B Warrants and the Tranche C Warrants will expire at May 4, 2012 at 5:00 p.m. Eastern time. 

 

	 	2.	The term “Warrant” as used in the Warrant shall be deemed to refer to the Warrant as amended hereby. 


 

	 	3.	Except as specifically modified herein, the remaining provisions of the Warrant remain in full force and effect. 


IN WITNESS WHEREOF, the undersigned has caused this Amendment to be executed by a duly authorized officer as of the date first set forth
above. 
 ROCKWELL MEDICAL TECHNOLOGIES, INC. 
 By: /s/ Thomas E. Klema  
 Thomas E. Klema 

Chief Financial Officer and Treasurer
II 

112TH CONGRESS 

2D SESSION S. 2684 

To extend the temporary suspension of duty on Disflamoll TOF. 

IN THE SENATE OF THE UNITED STATES 

MAY 7, 2012 

Mr. CASEY introduced the following bill; which was read twice and referred 

to the Committee on Finance 

A BILL 

To extend the temporary suspension of duty on Disflamoll 

TOF. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. DISFLAMOLL TOF. 

4 (a) IN GENERAL.—Heading 9902.24.62 of the Har5 monized Tariff Schedule of the United States (relating to 

6 phosphoric acid, tris (2-ethylhexyl) ester) is amended by 

7 striking the date in the effective period column and insert8 ing ‘‘12/31/2015’’. 

9 (b) EFFECTIVE DATE.—The amendment made by 

10 subsection (a) applies to goods entered, or withdrawn from 


tjames on DSK6SPTVN1PROD with BILLS
2 

•S 2684 IS

1 warehouse for consumption, on or after the 15th day after 

2 the date of the enactment of this Act. 

Æ 


tjames on DSK6SPTVN1PROD with BILLS
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This Schedule contains summary financial information extracted from the
financial statements contained in the body of the accompanying Form 10-K and is
qualified in its entirety by reference to such financial statements.
</LEGEND>
<MULTIPLIER>                                    1,000

<S>                                             <C>
<PERIOD-TYPE>                                   12-Mos
<FISCAL-YEAR-END>                               Jan-29-2000
<PERIOD-END>                                    Jan-29-2000
<CASH>                                              12,776
<SECURITIES>                                             0
<RECEIVABLES>                                       31,733
<ALLOWANCES>                                         3,599
<INVENTORY>                                         58,689
<CURRENT-ASSETS>                                   106,053
<PP&E>                                              57,380
<DEPRECIATION>                                       8,406
<TOTAL-ASSETS>                                     324,482
<CURRENT-LIABILITIES>                               57,506
<BONDS>                                            105,915
<PREFERRED-MANDATORY>                                  500
<PREFERRED>                                              0
<COMMON>                                               131
<OTHER-SE>                                         153,865
<TOTAL-LIABILITY-AND-EQUITY>                       324,482
<SALES>                                            366,802
<TOTAL-REVENUES>                                   366,802
<CGS>                                              193,287
<TOTAL-COSTS>                                      358,817
<OTHER-EXPENSES>                                         0
<LOSS-PROVISION>                                     1,664
<INTEREST-EXPENSE>                                  12,968
<INCOME-PRETAX>                                     (4,983)
<INCOME-TAX>                                           363
<INCOME-CONTINUING>                                  7,985
<DISCONTINUED>                                           0
<EXTRAORDINARY>                                          0
<CHANGES>                                                0
<NET-INCOME>                                        (5,346)
<EPS-BASIC>                                         (.42)
<EPS-DILUTED>                                         (.42)


</TABLE>
# Official Journal L 252/2007

| | ISSN 1725-2555 |
| --- | --- |
| Official Journal
  of the European Union | L 252 |
| | |
| English edition | Legislation | Volume 5027 September 2007 |

ISSN 1725-2555

Official Journal

of the European Union

L 252

English edition

Legislation

Volume 5027 September 2007

---

| Contents | | I   Acts adopted under the EC Treaty/Euratom Treaty whose publication is obligatory | page |
| --- | --- | --- | --- |
| | | REGULATIONS |
| | | Commission Regulation (EC) No 1105/2007 of 26 September 2007 establishing the standard import values for determining the entry price of certain fruit and vegetables | 1 |
| | | Commission Regulation (EC) No 1106/2007 of 26 September 2007 setting the allocation coefficient for issuing of licences applied for from 17 to 21 September 2007 to import sugar products under tariff quotas and preferential agreements | 3 |

Contents

I   Acts adopted under the EC Treaty/Euratom Treaty whose publication is obligatory

page

REGULATIONS

Commission Regulation (EC) No 1105/2007 of 26 September 2007 establishing the standard import values for determining the entry price of certain fruit and vegetables

1

Commission Regulation (EC) No 1106/2007 of 26 September 2007 setting the allocation coefficient for issuing of licences applied for from 17 to 21 September 2007 to import sugar products under tariff quotas and preferential agreements

3

| | | Corrigenda |
| --- | --- | --- |
| | * | Corrigendum to Council Regulation (EC) No 682/2007 of 18 June 2007 imposing a definitive anti-dumping duty and collecting definitively the provisional duty imposed on imports of certain prepared or preserved sweetcorn in kernels originating in Thailand (OJ L 159, 20.6.2007) | 7 |

Corrigenda

*

Corrigendum to Council Regulation (EC) No 682/2007 of 18 June 2007 imposing a definitive anti-dumping duty and collecting definitively the provisional duty imposed on imports of certain prepared or preserved sweetcorn in kernels originating in Thailand (OJ L 159, 20.6.2007)

7

| EN | Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period.
  The titles of all other Acts are printed in bold type and preceded by an asterisk. |
| --- | --- |

EN

Acts whose titles are printed in light type are those relating to day-to-day management of agricultural matters, and are generally valid for a limited period.

The titles of all other Acts are printed in bold type and preceded by an asterisk.
Exhibit 10.10


Exhibit 10.10
Court of Appeals

Sixth Appellate District of Texas

J U D G M E N T

Timothy Decarlos Sims, Appellant

No. 06-19-00016-CR v.

The State of Texas, Appellee

Appeal from the 6th District Court of Lamar 

County, Texas (Tr. Ct. No. 27895). Opinion 

delivered by Chief Justice Morriss, Justice 

Burgess and Justice Stevens participating.

As stated in the Court’s opinion of this date, we find no error in the judgment of the court 

below. We affirm the judgment of the trial court.

We note that the appellant, Timothy Decarlos Sims, has adequately indicated his inability 

to pay costs of appeal. Therefore, we waive payment of costs.

RENDERED JULY 31, 2019

BY ORDER OF THE COURT

JOSH R. MORRISS, III

CHIEF JUSTICE

ATTEST:

Debra K. Autrey, Clerk
Petition for Writ of Mandamus Dismiss ed and Memorandum Opinion filed

August 9, 2018.

In The



## Fourteenth Court of Appeals

NO. 14- 18 -00584- CV

IN RE ROBERT ATRIPAL DI , Relator

ORIGINAL PROCEEDING WRIT OF MANDAMUS 80th District Court Harris County, Texas Trial Court Cause No. 2018-16397



### MEMORANDUM OPINION
On July 18, 2018, relator Robert Atripaldi filed a petition for writ of
mandamus in this court. See Tex. Gov’t Code Ann. § 22.221 (West Supp. 2017 );
see also Tex. R. App. P. 52. Relator asks this court to compel the Honorable Larry Weiman, presiding judge of the 80th District Court of Harris County , to set aside his June 15, 2018 order granting real party interest’s emergency motion for leave to conduct discovery.2

On August 3, 2018, relator filed a motion to dismiss this original proceeding in order to effectuate the parties’ settlement. Relator’s requested relief in the petition is now moot. The motion is granted.
Accordingly, relator’s petition is ordered dismissed. We also deny relator’s emergency motion to stay as moot

.

PER CURIAM
Panel consists of Justices Jamison, Wise, and Jewell.
No. 07-40202

* Pursuant to 5

TH C IR. R. 47.5, the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5 TH C IR
. R. 47.5.4.

### IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 07-40202

ROBERT CLAYTON CROW Plaintiff - Appellant v. THERESA RELKIN; REX SPOTTEDBEAR; JOHN DOE; ROBERT BURBY; CARLOS ALCOCER; RICCI RYAN OSTERMAYER; JAMES YANAS; CITY OF TEXAS CITY, TEXAS Defendants - Appellees

Appeal from the United States District Court

Southern District of Texas USDC No. 3:05-CV-653
Before JONES, Chief Judge, and GARWOOD and JOLLY, Circuit Judges. PER CURIAM: * Robert Crow appeals the district court’s order granting summary judgment to the Defendants and awarding Defendants their costs. This Court has considered the record in light of the briefs and oral argument, and we affirm. The evidence does not establish that all reasonable police offi cers would have United States Court of Appeals

Fifth Circuit 

### F I L E D February 1, 2008 Charles R. Fulbruge III ClerkNo. 07-40202

2 found probable cause lacking under the facts of this case, and Defendants are therefore entitled toqualified immunity. Babb v. Dorman, 33 F.3d. 472, 477 (5th Cir. 1994

). We likewise find no abuse of discretion in the award of costs to Defendants. The judgment of the district court is AFFIRMED.
# Exhibit 32.1

# CERTIFICATION PURSUANT
TO18 U.S.C. SECTION 1350,AS ADOPTED PURSUANT BY

# SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly
Report of GFR Pharmaceuticals, Inc. on Form 10-QSB for the period ending June 30, 2004, as
filed with the Securities and Exchange Commission on the date hereof (the
Report), I, Richard Pierce, Chief Executive Officer of the Company, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the
          Securities Exchange Act of 1934; and
| | --- | -------------------------------------------------------------------------------------------------------------------------------

| | (2) | The information contained in the Report fairly presents, in all material
          respects, the financial condition and result of operations of the Company.
| | --- | -------------------------------------------------------------------------------------------------------------------------------------------------------------

By: /s/ Richard Pierce  Richard Pierce, CEO,
DirectorDate: August 12, 2004

A signed original of this written
statement required by Section 906, or other document authenticating, acknowledging, or
otherwise adopting the signature that appears in typed form within the electronic version
of this written statement has been provided to the Company and will be retained by the
Company and furnished to the Securities and Exchange Commission or its staff upon request.

---
SIERRA HEALTH SERVICES INC AND SUBSIDIARIES

                        COMPUTATION OF EARNINGS PER SHARE

                                   EXHIBIT 11

<TABLE>
<CAPTION>

                                                                THREE MONTHS ENDED                  SIX MONTHS ENDED
                                                              JUNE              JUNE             JUNE              JUNE
                                                              1997              1996             1997              1996



<S>                                                        <C>              <C>                <C>              <C>
NET INCOME......................................           $10,561,000      $10,211,000        11,959,000       $20,375,000

EARNINGS PER COMMON SHARE.......................                  $.59             $.58              $.67             $1.15

Weighted Average Number
 of Common Shares Outstanding...................            17,970,000       17,706,000        17,909,000        17,667,000

     .......................................................................................................................

PRIMARY EARNINGS PER COMMON
 AND COMMON SHARE
 EQUIVALENTS....................................                  $.58             $.56              $.66             $1.12

Weighted Average Number of
 Common and Common
 Equivalent Shares Outstanding..................            18,242,000       18,203,000        18,200,000        18,175,000

     .......................................................................................................................

FULLY DILUTED EARNINGS PER
  COMMON AND COMMON SHARE
  EQUIVALENTS...................................                  $.58             $.56              $.65             $1.12

Weighted Average Number of Common
 and Common Equivalent Shares Outstanding
Assuming Full Dilution..........................            18,316,000       18,204,000        18,304,000        18,176,000
</TABLE>


Note:    Common   Equivalent   Shares  represent  the  incremental   effect  of
          outstanding stock options and stock appreciation rights.
Exhibit 15.2

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in Registration Statement Nos. 333-10232,
333-11320, 333-190509 and 333-213861 on Form F-3 of our report dated 24 February
2016, relating to the 2015 consolidated financial statements (before retrospective adjustments to the financial statements and related disclosures discussed in Note 41) of Santander UK plc and subsidiaries (not presented herein) appearing in this
Annual Report on Form 20-F of Santander UK plc for the year ended 31 December 2017.



|                      
|----------------------
|/s/ DELOITTE LLP      
|                      
|London, United Kingdom
|                      
|7 March, 2018
Exhibit 32.1





CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the Quarterly Report of Royal Quantum Group, Inc. a Nevada corporation (the "Company") on Form 10-Q for the period ending September 30, 2010, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), Ron Ruskowsky, Chief Executive Officer of the Company, certifies to the best of his knowledge, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:





(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.





A signed original of this written statement required by Section 906 has been provided to Royal Quantum Group, Inc., and will be retained by Royal Quantum Group, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.











_/s/_________________________


Ron Ruskowsky


Chief Executive Officer


November 15, 2010
Exhibit 99.1
                                CEO Certification




                            CERTIFICATION PURSUANT TO
                                18 U.S.C. S 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In  connection  with the  Quarterly  Report of Laredo  Investment  Corp. on Form
10-QSB for the period  ending June 30, 2002,  as filed with the  Securities  and
Exchange  Commission  on the date  hereof (the  "Report"),  I,  Richard  Pierce,
President and Chief Executive  Officer of the Company,  certify,  pursuant to 18
U.S.C. S 1350, as adopted pursuant to Section 906 of the  Sarbanes-Oxley  Act of
2002, that, to the best of my knowledge and belief:

        (1)     the Report fully complies with the requirements of Section 13(a)
                or 15(d) of the Securities Exchange Act of 1934; and

        (2)     the information  contained in the Report fairly presents, in all
                material  respects,   the  financial  condition  and  result  of
                operations of the Company.



/s/ Richard Pierce
Richard Pierce, President and Chief Executive Officer
August 9, 2002
Exhibit
32.2
 CERTIFICATION
PURSUANT TO
 18
U.S.C. SECTION 1350,
 AS
ADOPTED PURSUANT TO
 SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
  In
connection with the Quarterly Report of Royal Quantum Group, Inc. a Nevada
corporation (the "Company") on Form 10-Q for the period ending June 30, 2008, as
filed with the Securities and Exchange Commission on the date hereof (the
"Report"), Ron Ruskowsky, Chief Financial Officer of the Company, certifies to
the best of his knowledge, pursuant to 18 U.S.C. § 1350, as adopted
pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
  (1)
              The
      Report fully complies with the requirements of Section 13(a) or 15(d) of
      the Securities Exchange Act of 1934;
and
  (2)
              The
      information contained in the Report fairly presents, in all material
      respects, the financial condition and result of operations of the
      Company.
  A signed
original of this written statement required by Section 906 has been provided to
Royal Quantum Group, Inc., and will be retained by Royal Quantum Group, Inc. and
furnished to the Securities and Exchange Commission or its staff upon
request.


/s/
      Ron RuskowskyRon
      Ruskowsky
                  Chief
      Financial Officer
                  August 15,
      2008
Exhibit 4.1



 Exhibit 4.1
NOT PRECEDENTIAL

UNITED STATES COURT OF APPEALS

FOR THE THIRD CIRCUIT

___________

No. 20-2124

___________

IN RE: JULIO AVILES, SR.,

Petitioner

____________________________________

On Petition for a Writ of Mandamus to the

United States District Court for the Middle District of Pennsylvania

(D.C. Nos. 1-15-cr-00181 & 1-20-cv-00290)

District Judge: Honorable John E. Jones, III

____________________________________

Submitted Pursuant to Fed. R. App. P. 21

on August 13, 2020

Before: AMBRO, GREENAWAY, JR., and BIBAS, Circuit Judges

(Opinion filed: September 10, 2020)

___________

OPINION*

___________

PER CURIAM

Julio Aviles, Sr., is a federal prisoner currently awaiting resentencing in the United 

States District Court for the Middle District of Pennsylvania. In February 2020, while 

resentencing was pending, Aviles filed a pro se motion pursuant to 28 U.S.C. § 2255 

* This disposition is not an opinion of the full Court and pursuant to I.O.P. 5.7 does not 

constitute binding precedent.
2

challenging his convictions. That motion was docketed in his criminal case, M.D. Pa. 

Crim. No. 1:15-cr-00181, and a new civil case was also opened for the matter, M.D. Pa. 

Civ. No. 1:20-cv-00290. In May 2020, Aviles filed a motion in the civil matter asking the 

District Court to adjudicate his §2255 motion. The District Court then entered an order in 

the criminal matter dismissing the §2255 motion without prejudice as premature. The District Court’s order was not docketed in the civil matter and, although the District Court 

directed counsel to provide Aviles with a copy of the order, it appears that Aviles never 

received one. As a result, on May 26, 2020, Aviles filed in this Court a petition for writ of 

mandamus asking us to compel the District Court to adjudicate his §2255 motion. 

Given that the District Court has already adjudicated the §2255 motion, this case does 

not present a live controversy. Therefore, we will dismiss the mandamus petition as moot. 

See Blanciak v. Allegheny Ludlum Corp., 77 F.3d 690, 698–99 (3d Cir. 1996). This dismissal is without prejudice to Aviles’ ability to file a §2255 motion after resentencing.